PMD-026 demonstrates high specificity for the four RSK isoforms in vitro (IC50 0.7–2 nM) with good selectivity as well as in vivo efficacy in mouse xenograft tumor models of TNBC. The gene discussed is RPS6KA2; the disease is neoplasm.